Presenter's Information
Freek W.A. Verheugt, MD
Country | Netherlands |
Specialty | Interventional Cardiologist |
- Optimal Antithrombotic Treatment in Patients with AF Undergoing PCI
- Atrial Fibrillation & PCI: Many Regimens, Little Solutions!
- Atrial Fibrillation & Antithrombotic Regimens: Finding the \"Sweet-Spot\" from RCTs
- DAPT and Beyond 12 Months: Which One and How Long?
- When AF & ACS Collide: Many Regimens, Little Solutions!
- Remnant Risk of Secondary MACE/ Mortality After Index AMI
- Optimizing Duration of Anti-platelet Therapy Following ACS
- For: Nothing to Lose, More to Gain - The ATLANTIC Trial
- New DAPT and Beyond 12 Months: Which One and How Long?
- Nothing to Lose, More to Gain - The ATLANTIC Trial
- Possible Role of Rivaroxaban in ACS Patients: Lessions Learned from ATLAS ACS 2 TIMI 51
- Factor Xa Inhibitors: The Forgotten Way, A Viable Option to Go
- Factor Xa Inhibitors: Old Problems and New Solutions